Anacor Pharmaceuticals appoints arbitrator to resolve its dispute with Valeant Pharmaceuticals Anacor Pharmaceuticals today announced that the arbitrator appointed to resolve it is dispute with Valeant Pharmaceuticals, Inc. , has released an Interim Last Award in favor of Anacor, awarding Anacor $100 million in damages in addition to all costs of the arbitration and sensible attorney's fees. The parties may apprise the arbitrator of any problems not resolved in the Interim Final Award purchase within ten times, and responses to any such submission are due within fifteen days of the date of the Interim Last Award. If no submissions are made, this Interim Last Award will become final The Final Award will end up being submitted to the courtroom of suitable jurisdiction for confirmation and enforcement.Anna Hospital, Como, President and Italy of Italian Association of Pacing and Arrhythmias. We would like regulatory approvals for revised labeling and up to date software program for these systems in main markets by 2017. MRI compatibility hasn’t received regulatory acceptance in all geographies.. CPAP for sleep apnea may reduce center risks People who use face masks for sleep apnea may have one more reason to breathe much easier at night.